Add Company
Join Now

Isomab Ltd Revenue and Competitors

License our Company Data API

Nottingham, UK

Location

$10M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Isomab Ltd's estimated annual revenue is currently $2.5M per year.(i)
  • Isomab Ltd's estimated revenue per employee is $155,000
  • Isomab Ltd's total funding is $10M.

Employee Data

  • Isomab Ltd has 16 Employees.(i)
  • Isomab Ltd grew their employee count by 23% last year.

Isomab Ltd's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP, Pre-clinical DevelopmentReveal Email/Phone
3
VP, Clinical DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M35-12%N/AN/A
#2
$16.3M1054%N/AN/A
#3
$107.2M49425%$292MN/A
#4
$2.6M83030%$631.7MN/A
#5
$18.1M117-8%$81MN/A
#6
$1.2M27112%$440MN/A
#7
$54.6M2820%$132.9MN/A
#8
$9.3M60-37%N/AN/A
#9
$21.2M13712%N/AN/A
#10
$408.2M164611%£994.6MN/A
Add Company

What Is Isomab Ltd?

IsomAb is taking a different approach to identify, evaluate and develop isoform specific antibodies to treat disease where patients currently have limited or no treatment options.\nIsomAb is developing isoform specific antibodies and it has identified, using a combined bioinformatics/knowledge-based platform approach, ISM-001 which specifically inhibits the VEGF-A165b isoform of Vascular Endothelial Growth Factor-A (VEGF-A); based on 20 years of research by our two Founders, the evidence shows reducing serum levels of VEGF-A165b is key to ensuring new blood vessel formation in patients with ischemic disease.

keywords:N/A

$10M

Total Funding

16

Number of Employees

$2.5M

Revenue (est)

23%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.6M16-11%N/A
#2
$2.5M1813%N/A
#3
$1.5M1820%N/A
#4
$2.7M1850%N/A
#5
$3.3M18N/AN/A